Sleep Medicine Makes A Difference for Pulmonary & Critical Care Medicine Patients

The University of Michigan Sarcoidosis Clinic officially began seeing patients on July 5, 2011.  

(888) 284-5864 Ann Arbor or (810) 227-9510 Brighton, MI

Education and Training

Offering outstanding training in pulmonary and critical care medicine focusing on the development of both clinicians and scientists. Read more ...

Pulmonary & Critical Care Medicine

 

         Division of Pulmonary & Critical Medicine Faculty and Fellows

The Division of Pulmonary and Critical Care Medicine (PCCM) is committed to caring for critically ill patients and patients with lung disease. This requires not only that we provide the best possible care, but that we convey these skills to trainees and that we develop novel approaches to understanding and managing these diseases through basic science and clinical and outcomes research.Our mission is to deliver excellent patient care, to develop new knowledge about the lung in health and disease, and to train individuals to be outstanding clinicians and researchers.

What We Focus On

  • Patient Care Pulmonary and Critical Care Medicine serves as a regional referral center for both the inpatient and outpatient evaluation of a broad range of pulmonary disorders. Learn more »
  • Education PCCM assumes a prominent role in the overall educational mission of the Department of Internal Medicine and Medical School at Michigan. Our educators have been recognized as some of the top within the institution and serve in major leadership roles within the educational programs. Learn more »
  • Research Research performed within the PCCM has greatly impacted our understanding of basic lung biology, disease pathogenesis, and targeted therapeutics. Learn more »  
 

News

Events

May 8, 2015
Add to Calendar

Internal Medicine Grand Rounds

12:00 pm

Charting our Future Together: Setting an Agenda

Ford Auditorium, A201 University Hospital

Biography

Gary H. Gibbons, M.D., is Director of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH), where he oversees the third largest institute at the NIH, with an annual budget of more than $3 billion and a staff of 917 federal employees.

The NHLBI provides global leadership for research, training, and education programs to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.

Prior to being named director of the NHLBI, Gibbons served as a member of the National Heart, Lung, and Blood Advisory Council (NHLBAC) from 2009-2012. He was also a member of the NHLBI Board of Extramural Experts (BEE), a working group of the NHLBAC.

Before joining the NHLBI, Gibbons served as the founding director of the Cardiovascular Research Institute, chairperson of the Department of Physiology, and professor of physiology and medicine at the Morehouse School of Medicine, in Atlanta.

Under his leadership of the Cardiovascular Research Institute, Gibbons directed NIH-funded research in the fields of vascular biology, genomic medicine, and the pathogenesis of vascular diseases. During his tenure, the Cardiovascular Research Institute emerged as a center of excellence, leading the way in discoveries related to the cardiovascular health of minority populations. Gibbons received several patents for innovations derived from his research in the fields of vascular biology and the pathogenesis of vascular diseases.

Gibbons earned his undergraduate degree from Princeton University in Princeton, N.J., and graduated magna cum laude from Harvard Medical School in Boston. He completed his residency and cardiology fellowship at the Harvard-affiliated Brigham and Women's Hospital in Boston. Prior to joining the Morehouse School of Medicine in 1999, Gibbons was a member of the faculty at Stanford University in Stanford, Calif., from 1990-1996, and at Harvard Medical School from 1996-1999. 

Throughout his career, Gibbons has received numerous honors, including election to the Institute of Medicine of the National Academies of Sciences; selection as a Robert Wood Johnson Foundation Minority Faculty Development Awardee; selection as a PewFoundation Biomedical Scholar; and recognition as an Established Investigator of the American Heart Association (AHA).